Agile Therapeutics, Inc. (AGRX) analyst actions
Rating and price-target actions on AGRX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AGRX overview →
1 measured AGRX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024 | Press release | — | -3.29% |
Keep exploring
More AGRX: earnings → · SEC filings → · AGRX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Organovo Holdings, Inc. (ONVO) | 87 | -0.95% | 37% |
| Flurotech Ltd (TEST_CDNX) | 87 | 0.00% | 41% |
| INTEGRATED BIOPHARMA INC (INBP) | 86 | 0.00% | 45% |
| NORTHWEST BIOTHRPUTCS INC (NWBO) | 86 | -0.49% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.